Multimodal assessment of disease activity in glioblastoma-Reference-Cited by-同舟云学术

Multimodal assessment of disease activity in glioblastoma

Published:2021-04-20 Issue:21-22 Volume:133 Page:1148-1154
ISSN:0043-5325
Container-title:Wiener klinische Wochenschrift
language:en
Short-container-title:Wien Klin Wochenschr

Author:

Tinchon Alexander,Marhold Franz,Calabek-Wohinz Bernadette,Hainz Katharina,Tesar-Pelz Martina,Minear Gregory,Freydl Elisabeth,Blauensteiner Katrin,Heinz Gertraud,Oberndorfer Stefan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00508-021-01859-2.pdf

Reference32 articles.

1. Schiff D, Wen P, editors. Cancer neurology in clinical practice. Totowa, NJ: Humana Press Inc; 2003.

2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005;352(10):987–96.

3. Eisele SC, Wen PY, Lee EQ. Assessment of brain tumor response: RANO and its offspring. Curr Treat Options Oncol. 2016;17(7):35.

4. Rees JH. Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol. 2011;84(2):82–9.

5. Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ. Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol. 2010;9(9):906–20.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability and feasibility of cognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review;Neuro-Oncology Practice;2022-12-26